Ho-Sam Ahn

1.3k total citations
27 papers, 967 citations indexed

About

Ho-Sam Ahn is a scholar working on Hematology, Genetics and Organic Chemistry. According to data from OpenAlex, Ho-Sam Ahn has authored 27 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 11 papers in Genetics and 10 papers in Organic Chemistry. Recurrent topics in Ho-Sam Ahn's work include Blood Coagulation and Thrombosis Mechanisms (17 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (11 papers) and Synthesis and Catalytic Reactions (6 papers). Ho-Sam Ahn is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (17 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (11 papers) and Synthesis and Catalytic Reactions (6 papers). Ho-Sam Ahn collaborates with scholars based in United States, United Kingdom and Czechia. Ho-Sam Ahn's co-authors include George Boykow, Carolyn Foster, Samuel Chackalamannil, Allen Barnett, Michael P. Graziano, Madhu Chintala, William J. Greenlee, Yan Xia, Jacqueline Agans-Fantuzzi and Yunsheng Hsieh and has published in prestigious journals such as Circulation, Journal of Medicinal Chemistry and Biochemical Pharmacology.

In The Last Decade

Ho-Sam Ahn

27 papers receiving 897 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ho-Sam Ahn United States 16 373 287 273 224 168 27 967
George Boykow United States 16 371 1.0× 331 1.2× 243 0.9× 226 1.0× 165 1.0× 29 1.1k
Marie A. Holahan United States 22 290 0.8× 278 1.0× 206 0.8× 173 0.8× 22 0.1× 50 1.1k
Ross Bentley United States 19 112 0.3× 375 1.3× 369 1.4× 143 0.6× 56 0.3× 33 951
Jennifer Yeung United States 15 164 0.4× 472 1.6× 183 0.7× 38 0.2× 26 0.2× 24 981
Thomas E. Steinbacher United States 15 184 0.5× 100 0.3× 180 0.7× 38 0.2× 108 0.6× 30 469
Eric Blasko United States 9 194 0.5× 212 0.7× 103 0.4× 41 0.2× 35 0.2× 12 741
Inge M. Michel United States 18 124 0.3× 412 1.4× 51 0.2× 103 0.5× 70 0.4× 45 870
Lubing Zhou United States 16 110 0.3× 555 1.9× 77 0.3× 71 0.3× 54 0.3× 33 1.0k
Kayoko Mihara Japan 12 72 0.2× 298 1.0× 90 0.3× 125 0.6× 20 0.1× 19 672
Harold Goldenberg United States 14 74 0.2× 218 0.8× 101 0.4× 47 0.2× 55 0.3× 29 488

Countries citing papers authored by Ho-Sam Ahn

Since Specialization
Citations

This map shows the geographic impact of Ho-Sam Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ho-Sam Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ho-Sam Ahn more than expected).

Fields of papers citing papers by Ho-Sam Ahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ho-Sam Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ho-Sam Ahn. The network helps show where Ho-Sam Ahn may publish in the future.

Co-authorship network of co-authors of Ho-Sam Ahn

This figure shows the co-authorship network connecting the top 25 collaborators of Ho-Sam Ahn. A scholar is included among the top collaborators of Ho-Sam Ahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ho-Sam Ahn. Ho-Sam Ahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chackalamannil, Samuel, Yan Xia, Keith Eagen, et al.. (2012). Discovery of nor-seco himbacine analogs as thrombin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 22(7). 2544–2549. 11 indexed citations
2.
Xia, Yan, Samuel Chackalamannil, William J. Greenlee, et al.. (2010). Discovery of a vorapaxar analog with increased aqueous solubility. Bioorganic & Medicinal Chemistry Letters. 20(22). 6676–6679. 19 indexed citations
3.
4.
Xia, Yan, Samuel Chackalamannil, Martin C. Clasby, et al.. (2007). Himbacine derived thrombin receptor (PAR-1) antagonists: SAR of the pyridine ring. Bioorganic & Medicinal Chemistry Letters. 17(16). 4509–4513. 4 indexed citations
5.
Chackalamannil, Samuel, Yan Xia, Keith Eagen, et al.. (2007). Heterotricyclic Himbacine Analogs as Potent, Orally Active Thrombin Receptor (Protease Activated Receptor-1) Antagonists. Journal of Medicinal Chemistry. 50(21). 5147–5160. 24 indexed citations
6.
Clasby, Martin C., Samuel Chackalamannil, Michael Czarniecki, et al.. (2007). Himbacine derived thrombin receptor antagonists: Discovery of a new tricyclic core. Bioorganic & Medicinal Chemistry Letters. 17(13). 3647–3651. 17 indexed citations
7.
Xia, Yan, Samuel Chackalamannil, Tze‐Ming Chan, et al.. (2006). Himbacine derived thrombin receptor (PAR-1) antagonists: Structure–activity relationship of the lactone ring. Bioorganic & Medicinal Chemistry Letters. 16(18). 4969–4972. 5 indexed citations
8.
Chackalamannil, Samuel, Yan Xia, William J. Greenlee, et al.. (2005). Discovery of Potent Orally Active Thrombin Receptor (Protease Activated Receptor 1) Antagonists as Novel Antithrombotic Agents. Journal of Medicinal Chemistry. 48(19). 5884–5887. 106 indexed citations
9.
Clasby, Martin C., Samuel Chackalamannil, Michael Czarniecki, et al.. (2005). Discovery and synthesis of a novel series of quinoline-based thrombin receptor (PAR-1) antagonists. Bioorganic & Medicinal Chemistry Letters. 16(6). 1544–1548. 20 indexed citations
10.
Chackalamannil, Samuel, Ho-Sam Ahn, Yan Xia, Darı́o Doller, & Carolyn Foster. (2003). Potent Non-Peptide Thrombin Receptor Antagonists. PubMed. 1(1). 37–45. 9 indexed citations
11.
Ahn, Ho-Sam, Samuel Chackalamannil, George Boykow, Michael P. Graziano, & Carolyn Foster. (2003). Development of Proteinase-Activated Receptor 1 Antagonists as Therapeutic Agents for Thrombosis, Restenosis and Inflammatory Diseases. Current Pharmaceutical Design. 9(28). 2349–2365. 29 indexed citations
12.
Chackalamannil, Samuel, Darı́o Doller, Keith Eagen, et al.. (2001). Potent, low molecular weight thrombin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 11(21). 2851–2853. 13 indexed citations
13.
14.
Ahn, Ho-Sam, Leyla Arik, George Boykow, et al.. (1999). Structure-activity relationships of pyrroloquinazolines as thrombin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 9(14). 2073–2078. 38 indexed citations
15.
Ahn, Ho-Sam, Carolyn Foster, George Boykow, et al.. (1997). Binding of a Thrombin Receptor Tethered Ligand Analogue to Human Platelet Thrombin Receptor. Molecular Pharmacology. 51(2). 350–356. 46 indexed citations
16.
Vemulapalli, Subbarao, Robert W. Watkins, Madhu Chintala, et al.. (1996). Antiplatelet and Antiproliferative Effects of SCH 51866, a Novel Type 1 and Type 5 Phosphodiesterase Inhibitor. Journal of Cardiovascular Pharmacology. 28(6). 862–869. 45 indexed citations
17.
Ahn, Ho-Sam, Michael A. Foster, Leyla Arik, George Boykow, & Carolyn Foster. (1995). Cyclic nucleotide phosphodiesterase isozymes in rat mesangial cells. European Journal of Pharmacology Molecular Pharmacology. 289(1). 49–57. 4 indexed citations
18.
Chiu, Peter J.S., Glen Tetzloff, Ho-Sam Ahn, & Edmund J. Sybertz. (1988). Effects of BRL 34915, a putative K channel opener, on transmembrane 45Ca movements in rabbit aortic smooth muscle. European Journal of Pharmacology. 155(3). 229–237. 14 indexed citations
19.
Watkins, Robert W., et al.. (1987). Topical Ocular Hypotensive Effects of the Novel Angiotensin Converting Enzyme Inhibitor SCH 33861 in Conscious Rabbits. Journal of Ocular Pharmacology and Therapeutics. 3(4). 295–307. 42 indexed citations
20.
Barnett, Allen, Ho-Sam Ahn, William Billard, et al.. (1986). Relative activities of SCH 23390 and its analogs in three tests for D1/DA1 dopamine receptor antagonism. European Journal of Pharmacology. 128(3). 249–253. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George Boykow Breakdown of academic impact, for papers by Marie A. Holahan Breakdown of academic impact, for papers by Ross Bentley Breakdown of academic impact, for papers by Jennifer Yeung Breakdown of academic impact, for papers by Thomas E. Steinbacher Breakdown of academic impact, for papers by Eric Blasko Breakdown of academic impact, for papers by Inge M. Michel Breakdown of academic impact, for papers by Lubing Zhou Breakdown of academic impact, for papers by Kayoko Mihara Breakdown of academic impact, for papers by Harold Goldenberg
Rankless by CCL
2026